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ligand from receptor. Ligand and receptor are sorted, and the ligand is targeted to lysosomes for degradation. The receptor is either
Insulin degradation
Early studies of the cellular degradation of insulin provided morphological evidence that insulin was localized in lysosomes (40). Coupled with biochemical evidence that chloroquine, a lysosomotropic agent (51), inhibited insulin degradation, it was widely held that insulin degradation occurred in the lysosome.
With the subsequent accumulation of evidence that prelysosomal compartments might also acidify and accumulate chioroquine (reclassified an acidotropic agent) (52), insulin degradation and the intracellular structures involved therein have recently been examined anew. Insulin protease activity has been found at the plasma membrane (53), in the cytosol (54, 55), and in endosomes (53, 56, 57). Inhibitor studies, metal requirements, and comparisons of proteolytic products have suggested that the activities at these distinct subcellular locations may be due to the same enzyme (54, 56, 58). Characterization of the protease indicates that it is a thiol protease with a neutral pH optimum (54, 55). Further studies of insulin degradation occurring in the endosomes have been performed with endosomes isolated from intact liver (56) or in a cell-free system utilizing endosomes preloaded with "51-labeled insulin (57). In these studies, proteolysis of insulin occurs with a half-time of 6 mm. The protease is specific for insulin, and does not degrade epidermal growth factor or prolactin. Not only are proteolytic fragments of "51-labeled insulin generated by the
In contrast to the purified insulin protease, which has optimal enzymatic activity at pH 7 (54, 55), the insulin protease characterized in the cell-free endosomes demonstrates optimal activity between pH 5.0 and 5.5. The endosomal system requires ATP for the maintenance of a pH gradient across the endosomal membrane. Because acidification augments the release of insulin from the receptor, the question was then posed: Is the insulin protease active on insulin bound to the receptor, or does the substrate for the enzyme have to be free in the lumen of the endosome?
The data presented by Posner, Bergeron, and co-workers (57) with the cell-free endosomal system indicate that inhibition of the release of insulin from the receptor reduces the degradation of insulin.
These data support the conclusion that free insulin is the substrate for the protease. Localization of the insulin protease activity to cytosol, plasma membrane, and endosomes is intriguing. If the physiologically significant location of the protease is the endosomal compartment, and if the enzymes in all three compartments are identical, how is the cytosolic enzyme inserted into the endosome, and is this insertion process a locus for cellular regulation of the degradation of insulin? These questions remain to be addressed. and 2) the interaction of the receptor with insulin, which modifies not only the rates at which the receptor moves through the subcellular compartments, but may also change the route itself. Aspects of the path followed by the receptor appear to be cell type-specific. Whether the pathway followed by the receptor, or the rate with which it traverses that path, influences the sensitivity of the cell to insulin remains to be determined.
The insulin receptor kinase
As seems to be the case with many macromolecules, our knowledge of the biosynthesis and synthetic assembly of the insulin receptor has out-stripped our understanding of the mechanisms responsible for its inactivation and degradation.
However, from any vantage point, our understanding of the dynamic cellular processing of the insulin receptor and the role it plays in cellular homeostasis is far from complete, and remains a fertile area of investigation.
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